Related references
Note: Only part of the references are listed.Pharmacodynamic study using FLT PET/CT in advanced solid malignancies treated with a sequential combination of X-82 and docetaxel
Matthew Scarpelli et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
Using Radiolabeled 3′-Deoxy-3′-18F-Fluorothymidine with PET to Monitor the Effect of Dexamethasone on Non-Small Cell Lung Cancer
Christopher McHugh et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Dynamic 18F-FLT PET imaging of spatiotemporal changes in tumor cell proliferation and vasculature reveals the mechanistic actions of anti-angiogenic therapy
Matthew Scarpelli et al.
PHYSICS IN MEDICINE AND BIOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Correlations of 18F-FDG and 18F-FLT uptake on PET with Ki-67 expression in patients with lung cancer: a meta-analysis
Guohua Shen et al.
ACTA RADIOLOGICA (2018)
Prospective Study of Serial Imaging Comparing Fluorodeoxyglucose Positron Emission Tomography (PET) and Fluorothymidine PET During Radical Chemoradiation for Non-Small Cell Lung Cancer: Reduction of Detectable Proliferation Associated With Worse Survival
Sarah Everitt et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Preclinical Applications of 3 '-Deoxy-3 '-[F-18]Fluoro-thymidine in Oncology - A Systematic Review
Sonja Schelhaas et al.
THERANOSTICS (2017)
A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB-IIIA resectable NSCLC
John P. Crandall et al.
EJNMMI RESEARCH (2017)
The role of radionuclide probes for monitoring anti-tumor drugs efficacy: A brief review
Renata Salgado Fernandes et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Comparison of Positron Emission Tomography Using 2-[18F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[18F]-fluorothymidine in Lung Cancer Imaging
Fu-Li Wang et al.
CHINESE MEDICAL JOURNAL (2016)
A systematic review on [18F]FLT-PET uptake as a measure of treatment response in cancer patients
V. R. Bollineni et al.
EUROPEAN JOURNAL OF CANCER (2016)
Performance of FLT-PET for pulmonary lesion diagnosis compared with traditional FDG-PET: A meta-analysis
Zixing Wang et al.
EUROPEAN JOURNAL OF RADIOLOGY (2015)
Early reduction in tumour [18F]fluorothymidine (FLT) uptake in patients with non-small cell lung cancer (NSCLC) treated with radiotherapy alone
Ioannis Trigonis et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Accuracy of FDG-PET to Diagnose Lung Cancer in Areas With Infectious Lung Disease A Meta-analysis
Stephen A. Deppen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Differential 18F-FDG and 18F-FLT Uptake on Serial PET/CT Imaging Before and During Definitive Chemoradiation for Non-Small Cell Lung Cancer
Sarah J. Everitt et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Ki-67 is a strong prognostic marker of non-small cell lung cancer when tissue heterogeneity is considered
Kazuhiro Tabata et al.
BMC CLINICAL PATHOLOGY (2014)
The Clinical Viewpoint: Definitions, Limitations of RECIST, Practical Considerations of Measurement
Liza C. Villaruz et al.
CLINICAL CANCER RESEARCH (2013)
Prognostic Impact of [18F]Fluorothymidine and [18F]Fluoro-D-Glucose Baseline Uptakes in Patients with Lung Cancer Treated First-Line with Erlotinib
Matthias Scheffler et al.
PLOS ONE (2013)
Pemetrexed Induced Thymidylate Synthase Inhibition in Non-Small Cell Lung Cancer Patients: A Pilot Study with 3′-Deoxy-3′-[18F]fluorothymidine Positron Emission Tomography
Virginie Frings et al.
PLOS ONE (2013)
Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab
Gang Chen et al.
BMC MEDICINE (2012)
Progression-free survival as a clinical trial endpoint in advanced renal cell carcinoma
Sebastien J. Hotte et al.
Current Oncology (2012)
Correlation between Ki-67 immunohistochemistry and 18F-Fluorothymidine uptake in patients with cancer: A systematic review and meta-analysis
A. Chalkidou et al.
EUROPEAN JOURNAL OF CANCER (2012)
Imaging proliferation of 18F-FLT PET/CT correlated with the expression of microvessel density of tumour tissue in non-small-cell lung cancer
Wenfeng Yang et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
3′-Deoxy-3′-18F-Fluorothymidine PET/CT to Guide Therapy with Epidermal Growth Factor Receptor Antagonists and Bcl-xL Inhibitors in Non-Small Cell Lung Cancer
Antonella Zannetti et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
The Efficacy of PET Staging for Small-Cell Lung Cancer A Systematic Review and Cost Analysis in the Australian Setting
Jeremy D. Ruben et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Guidelines for the role of FDG-PET/CT in lung cancer management
Hamdan AL-Jahdali et al.
Journal of Infection and Public Health (2012)
Thymidine Kinase 1 Upregulation Is an Early Event in Breast Tumor Formation
Melissa M. Alegre et al.
JOURNAL OF ONCOLOGY (2012)
Changes in 18F-Fluorodeoxyglucose and 18F-Fluorodeoxythymidine Positron Emission Tomography Imaging in Patients with Non-Small Cell Lung Cancer Treated with Erlotinib
Linda Mileshkin et al.
CLINICAL CANCER RESEARCH (2011)
Early Prediction of Nonprogression in Advanced Non-Small-Cell Lung Cancer Treated With Erlotinib By Using [18F]Fluorodeoxyglucose and [18F]Fluorothymidine Positron Emission Tomography
Thomas Zander et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Quantitative Analysis of Response to Treatment with Erlotinib in Advanced Non-Small Cell Lung Cancer Using 18F-FDG and 3′-Deoxy-3′-18F-Fluorothymidine PET
Deniz Kahraman et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
PET/CT with 3′-deoxy-3′-[18F]fluorothymidine for lung cancer patients receiving carbon-ion radiotherapy
Tsuneo Saga et al.
NUCLEAR MEDICINE COMMUNICATIONS (2011)
Simultaneous positron emission tomography (PET) assessment of metabolism with F-18-fluoro-2-deoxy-D-glucose (FDG), proliferation with F-18-fluoro-thymidine (FLT), and hypoxia with (18)fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): A pilot study
Pierre Vera et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Imaging of proliferation with 18F-FLT PET/CT versus 18F-FDG PET/CT in non-small-cell lung cancer
Wenfeng Yang et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Phase I Trial of the Irreversible EGFR and HER2 Kinase Inhibitor BIBW 2992 in Patients With Advanced Solid Tumors
Timothy A. Yap et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Different Modes of Transport for 3H-Thymidine, 3H-FLT, and 3H-FMAU in Proliferating and Nonproliferating Human Tumor Cells
David A. Plotnik et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
IMAGING CELLULAR PROLIFERATION DURING CHEMO-RADIOTHERAPY: A PILOT STUDY OF SERIAL 18F-FLT POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY IMAGING FOR NON-SMALL-CELL LUNG CANCER
Sarah Everitt et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Molecular imaging of proliferation in vivo: Positron emission tomography with [18F]fluorothymidine
Andreas K. Buck et al.
METHODS (2009)
[18F] Fluorothymidine Positron Emission Tomography before and 7 Days after Gefitinib Treatment Predicts Response in Patients with Advanced Adenocarcinoma of the Lung
Hee-Jung Sohn et al.
CLINICAL CANCER RESEARCH (2008)
A multicenter clinical trial on the diagnostic value of dual-tracer PET/CT in pulmonary lesions using 3′-deoxy-3′-18F-fluorothymidine and 18F-FDG
Jiahe Tian et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Comparison of 18F-FLT PET and 18F-FDG PET for preoperative staging in non-small cell lung cancer
Yuka Yamamoto et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Correlation of 18F-FLT and 18F-FDG uptake on PET with Ki-67 immunohistochemistry in non-small cell lung cancer
Yuka Yamamoto et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography
CS Yap et al.
CHEST (2006)
Clinical relevance of imaging proliferative activity in lung nodules
AK Buck et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Imaging DNA synthesis with [F-18]FMAU and positron emission tomography in patients with cancer
HH Sun et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
[18F]FLT PET for diagnosis and staging of thoracic tumours
H Dittmann et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Share Paper
